This hypothesis is supported by our finding that LVH and HFpEF were attenuated and cardiac metabolism was normalized in mice with CKD overlaying global or cardiomyocyte-specific deletion of FGFR4 compared to mice with CKD and intact cardiac FGFR4. This evidence concerns the gene FGFR4 and chronic kidney disease.